Synthesis and Pharmacological Evaluation of the Stereoisomers of 3-carba Cyclic-phosphatidic Acid
Overview
Authors
Affiliations
Cyclic phosphatidic acid (CPA) is a naturally occurring analog of lysophosphatidic acid (LPA) in which the sn-2 hydroxy group forms a five-membered ring with the sn-3 phosphate. Here, we describe the synthesis of R-3-CCPA and S-3-CCPA along with their pharmacological properties as inhibitors of lysophospholipase D/autotaxin, agonists of the LPA(5) GPCR, and blockers of lung metastasis of B16-F10 melanoma cells in a C57BL/6 mouse model. S-3CCPA was significantly more efficacious in the activation of LPA(5) compared to the R-stereoisomer. In contrast, no stereoselective differences were found between the two isomers toward the inhibition of autotaxin or lung metastasis of B16-F10 melanoma cells in vivo. These results extend the potential utility of these compounds as potential lead compounds warranting evaluation as cancer therapeutics.
Sanaa H, Touil S, Durandetti M, Samarat A ACS Omega. 2024; 9(44):44542-44548.
PMID: 39524664 PMC: 11541441. DOI: 10.1021/acsomega.4c06616.
Liu T, Yin D, Wang N, Li N, Dong G, Peng M Front Endocrinol (Lausanne). 2023; 14:1140094.
PMID: 37324256 PMC: 10266228. DOI: 10.3389/fendo.2023.1140094.
Design and Development of Autotaxin Inhibitors.
Jia Y, Li Y, Xu X, Tian Y, Shang H Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832985 PMC: 8622848. DOI: 10.3390/ph14111203.
Murph M, Jiang G, Altman M, Jia W, Nguyen D, Fambrough J Bioorg Med Chem. 2015; 23(17):5999-6013.
PMID: 26190462 PMC: 4554797. DOI: 10.1016/j.bmc.2015.06.054.
Fells J, Lee S, Fujiwara Y, Norman D, Lim K, Tsukahara R Mol Pharmacol. 2013; 84(3):415-24.
PMID: 23793291 PMC: 3876816. DOI: 10.1124/mol.113.087080.